APTARGROUP INC (ATR)       112.73  -0.06 (-0.05%)

112.73  -0.06 (-0.05%)

US0383361039 - Common Stock - After market: 112.73 0 (0%)


Fundamental Rating

5

Overall ATR gets a fundamental rating of 5 out of 10. We evaluated ATR against 27 industry peers in the Containers & Packaging industry. ATR has a great financial health rating, but there are some minor concerns on its profitability. ATR is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

4

ATR's Profit Margin of 7.12% is amongst the best of the industry. ATR does better than the industry average Profit Margin of 6.19%.
The Piotroski-F score of ATR is 7.00. This is a strong score and indicates good health and profitability for ATR.

ATR's Return On Assets of 5.91% is in line with the rest of the industry. The industry average Return On Assets is 5.91%.
ATR has a Return On Equity of 12.69%. This is below the industry average of 21.39%.
VS Industry

ROA (5.91%) VS Industry: 50% outperformed.

1.94
12.30

ROE (12.69%) VS Industry: 22% outperformed.

5.08
264.99

Profit Margin (7.12%) VS Industry: 68% outperformed.

2.25
12.02

Valuation

Valuation Rating

0

When comparing the current price to the book value of ATR, we can conclude it is valued correctly. It is trading at 3.93 times its book value.
With a Price/Earnings Ratio of 29.67, ATR can be considered very expensive at the moment.
With a Price/Earning Ratio of 29.67, ATR is valued a higher than the industry average, which is at 12.66. 96% of the companies listed in the same industry are cheaper than ATR!
With a Forward Price/Earnings Ratio of 29.61, ATR is valued very expensively.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the price book ratio of ATR to the average industry price book ratio of 2.63, ATR is valued more expensive than its industry peers.
When comparing the Enterprise Value to EBITDA ratio of ATR to the average industry ratio of 9.15, ATR is valued more expensive than its industry peers. 96% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (29.67) VS Industry: 4% outperformed.

151.83
6.27

Price/Book (3.93) VS Industry: 23% outperformed.

35.51
0.47

Enterprise Value/ EBITDA (13.43) VS Industry: 4% outperformed.

25.15
5.33

Growth

Growth Rating

5

Based on estimates for the next 5 years, ATR will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.52% on average per year.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
The earnings per share for ATR have decreased by -1.55% in the last year.
The Earnings Per Share has been growing slightly by 4.34% on average over the past 5 years.

Looking at the last year, ATR shows a small growth in Revenue. The Revenue has grown by 5.62% in the last year.
ATR shows a small growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 6.72% yearly.
The Revenue is expected to grow by 5.45% on average over the next 5 years.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS4.34% -1.01% -1.55% -5.18% -0.81% 4.97% 11.52%
Revenue6.72% 5.29% 5.62% 3.28% 2.25% 3.89% 5.45%

Health

Health Rating

7

With a Debt to Equity ratio of 0.55, ATR is one of the better performing companies in its industry. It outperforms 84% of its industry peers.
An Altman-Z score of 4.01 indicates that ATR is not in any danger for bankruptcy at the moment.
ATR has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.14. ATR has a better score than 88% of its industry peers.
ATR has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for ATR.

ATR has a Current Ratio of 1.56. This is a normal value and indicates that ATR is financially healthy and should not expect problems in meeting its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.53.
A Quick Ratio of 1.04 indicates that ATR should not have too much problems paying its short term obligations.
ATR has a Quick Ratio comparable to the industry average, which is at 1.04.
VS Industry

Debt/Equity (0.55) VS Industry: 84% outperformed.

14.83
0.00

Quick Ratio (1.04) VS Industry: 50% outperformed.

0.53
11.38

Current Ratio (1.56) VS Industry: 53% outperformed.

0.94
11.68

Altman-Z (4.01) VS Industry: 88% outperformed.

-2.16
7.53

Dividend

Dividend Rating

4

ATR has paid a dividend for at least 10 years, which is a reliable track record.
ATR has a Yearly Dividend Yield of 1.33%.
The dividend of ATR has a limited annual growth rate of 4.35%.
ATR pays out 41.90% of its income as dividend. This is a bit on the high side, but may be sustainable.

Compared to an average industry Dividend Yield of 2.18, ATR's dividend is way lower than its industry peers. On top of this 82% of the companies listed in the same industry pay a better dividend than ATR!
With a Dividend Yield of 1.33, ATR pays less dividend than the S&P500 average, which is at 2.40.
The Dividend Rate of ATR has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
VS Industry

Dividend Yield (1.33%) VS Industry: 18% outperformed.

0.29
8.32

APTARGROUP INC112.73

NYSE:ATR (1/27/2023, 4:05:00 PM)-0.06 (-0.05%)

After market: 112.73 0 (0%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Containers & Packaging
Earnings (Last) 10-27 2022-10-27/amc Earnings (Next) 02-15 2023-02-15
Inst Owners 87.43% Inst Owner Change -0.01%
Ins Owners 0.61% Ins Owner Change -1.33%
Market Cap 7.36B Analysts 72.86
Price Target 118.83 (5.41%)

Dividend
Dividend Yield 1.33% Dividend Growth 4.35%
DP 41.9% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -0.17%
Min EPS beat(2) -0.88% Max EPS beat(2) 0.54%
EPS beat(4) 2 Avg EPS beat(4) -0.01%
Min EPS beat(4) -0.88% Max EPS beat(4) 1.19%
Revenue beat(2) 1 Avg Revenue beat(2) -0.47%
Min Revenue beat(2) -1.46% Max Revenue beat(2) 0.51%
Revenue beat(4) 3 Avg Revenue beat(4) 1.03%
Min Revenue beat(4) -1.46% Max Revenue beat(4) 2.69%
PT rev (1m) -0.79% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 29.67
Fwd PE 29.61
P/S 2.2
P/FCF 83.77
P/OCF 17.93
P/B 3.93
P/tB 11.37
EV/EBITDA 13.43
EPS(TTM) 3.8 EY 3.37%
EPS(NY) 3.81 Fwd EY 3.38%
FCF(TTM) 1.35 FCFY 1.19%
OCF(TTM) 6.29 OCFY 5.58%
SpS 51.17 BVpS 28.72
TBVpS 9.92 PEG (NY) N/A
PEG (5Y) 6.84

Profitability
Industry RankSector Rank
ROA 5.91%
ROE 12.69%
ROIC 8.96%
ROICexc 9.33%
ROICexgc 15.58%
OM 11.63%
PM 7.12%
GM 35.34%
ROICexgc(3y) 16.15% ROICexcg growth 3Y -5.39%
ROICexcg growth 5Y -4.29% ROICexc(3y) 9.53%
ROICexc growth 3Y -7.35% ROICexc growth 5Y -8.23%
OM growth 3Y -4.98% OM growth 5Y -3.27%
PM growth 3Y 2.41% PM growth 5Y -3.03%
GM growth 3Y 0.85% GM growth 5Y 0.02%
F-Score 7 Asset Turnover 0.83

Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 13.57
Debt/EBITDA 1.91
Cap/Depr 137.17%
Profit Quality 36.93%
Current Ratio 1.56
Quick Ratio 1.04
Altman-Z 4.01
F-Score 7 WACC 7.25%
ROIC/WACC 2.15 Cap/Depr(3y) 124.18%
Cap/Depr(5y) 119.64% Profit Quality(3y) 93.95%
Profit Quality(5y) 82.1%

Growth
EPS 1Y -1.55% EPS 3Y -1.01%
EPS 5Y 4.34% EPS growth Q2Q 1.06%
EPS Next Y -5.18% EPS Next 2Y -0.81%
EPS Next 3Y 4.97% EPS Next 5Y 11.52%
Revenue growth 1Y 5.62% Revenue growth 3Y 5.29%
Revenue growth 5Y 6.72% Revenue growth Q2Q 1.38%
Revenue Next Year 3.28% Revenue Next 2Y 2.25%
Revenue Next 3Y 3.89% Revenue Next 5Y 5.45%
EBIT growth 1Y 3.51% EBIT growth 3Y 0.04%
EBIT growth 5Y 3.24% EBIT Next Year 64.88%
EBIT Next 3Y 23.63% EBIT Next 5Y 19.21%
FCF growth 1Y -68.93% FCF growth 3Y -18.28%
FCF growth 5Y -22.12% OCF growth 1Y -20.38%
OCF growth 3Y 5.04% OCF growth 5Y 2.24%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA